<DOC>
	<DOCNO>NCT00914680</DOCNO>
	<brief_summary>This treatment pilot study investigate clinical efficacy adverse effect magnetic seizure therapy ( MST ) patient currently experience unipolar bipolar depressive episode . The investigator perform add-on test assess clinical cognitive response treatment . It hypothesize MST antidepressant efficacy beneficial neurocognitive adverse effect profile .</brief_summary>
	<brief_title>Berlin Magnetic Seizure Therapy Depression Trial 01</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<criteria>Patient diagnose severe major depressive episode Patient chronic current MDE and/or history recurrent MDEs Patient acceptable clinical response due failure least 2 antidepressant treatment current episode Patient score &gt; 20 HAMD24 Patient stable current psychotropic medication least 4 week Patient &gt; 25 &lt; 80 year Atypical Depression psychotic depression ( accord DSM IV ) Other relevant psychiatric axis I axis II disease Relevant neurological disease Relevant cardiac pulmonary disease enhance anesthesiological risk ( ASA Score &gt; 3 ) Patient currently enrol another investigational study associate current study Patient history , evidence , significant brain malformation significant head injury</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2009</verification_date>
</DOC>